The following nominees were elected as directors of Willow for the ensuing year with the specific voting results being as follows:
Votes For | Votes Withheld | |||
Director | # | % | # | % |
Dr. | 36,177,987 | 99.18% | 300,231 | 0.82% |
36,166,230 | 99.14% | 311,988 | 0.86% | |
Dr. | 35,666,513 | 97.77% | 811,705 | 2.23% |
36,092,217 | 98.94% | 386,001 | 1.06% | |
35,671,203 | 97.79% | 807,015 | 2.21% | |
35,867,631 | 98.33% | 610,587 | 1.67% | |
36,160,678 | 99.13% | 317,540 | 0.87% |
In addition, shareholders approved the appointment of
Willow is a leading biotechnology company that develops and produces high-purity, plant derived ingredients for the personal care, food and beverage, and pharmaceutical markets. Willow's FutureGrown™ biotechnology platform allows large-scale production of pure, consistent, and sustainable products to benefit our B2B partners and their customers.
SOURCE
© Canada Newswire, source